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Abstract: Traumatic brain injury (TBI) induces blood-brain barrier (BBB) disruption, which contributes
to secondary injury of brain tissue and development of chronic cognitive decline. However, single mild
(m)TBI, the most frequent form of brain trauma disrupts the BBB only transiently. We hypothesized,
that co-morbid conditions exacerbate persistent BBB disruption after mTBI leading to long term
cognitive dysfunction. Since hypertension is the most important cerebrovascular risk factor in
populations prone to mild brain trauma, we induced mTBI in normotensive Wistar and spontaneously
hypertensive rats (SHR) and we assessed BBB permeability, extravasation of blood-borne substances,
neuroinflammation and cognitive function two weeks after trauma. We found that mTBI induced
a significant BBB disruption two weeks after trauma in SHRs but not in normotensive Wistar rats,
which was associated with a significant accumulation of fibrin and increased neuronal expression of
inflammatory cytokines TNFα, IL-1β and IL-6 in the cortex and hippocampus. SHRs showed impaired
learning and memory two weeks after mild TBI, whereas cognitive function of normotensive Wistar
rats remained intact. Future studies should establish the mechanisms through which hypertension
and mild TBI interact to promote persistent BBB disruption, neuroinflammation and cognitive decline
to provide neuroprotection and improve cognitive function in patients with mTBI.
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1. Introduction
Traumatic brain injury (TBI) is a serious health problem worldwide resulting in significant
chronic disabilities. After the mechanical force-induced primary brain injury, TBI initiates a variety
of pathophysiological processes leading to secondary brain damage [1–3], which contributes to
the development of long-term psychiatric problems and cognitive decline [2]. Disruption of the
blood-brain barrier plays a central role in the secondary pathological processes (reviewed in [4]),
leading to accumulation of blood-borne substances in the cerebral parenchyma, neuroinflammation and
consequent decline in higher brain function. Mild TBI (mTBI) is the most frequent form of head trauma,
typically affecting young athletes and the elderly population, who are prone to fall [5]. Interestingly,
mild TBI is likely to induce blood-brain barrier (BBB) disruption, but it has only a transient effect [6–8].
A growing body of research has established that preexisting comorbid medical conditions exacerbate
the deleterious effects of TBI (resulting in longer intensive care unit (ICU) stay and increased risk
for complications) [9]. The most frequently identified comorbid condition in TBI is hypertension
(in older individuals prevalence is about 38.8%) [10,11], which has been demonstrated to exacerbate
disruption of the BBB in various pathological conditions. For example, hypertensive aged mice were
found to exhibit increased permeability of the BBB, which is associated with neuroinflammation and
cognitive decline of the animals [12]. Based on these, in the present study we tested the hypothesis
that mild TBI induces persistent, long term disruption of the BBB in hypertensive rats, leading to
persistent accumulation of blood borne substances in the brain parenchyma, neuroinflammation and
cognitive decline.
2. Results
2.1. Mild TBI Induces Persistent Disruption of the Blood-Brain Barrier Which is Associated with Extravasation
and Accumulation of Blood Borne Fibrin in Cerebral Tissue of Spontaneously Hypertensive Rats
Spontaneously hypertensive rats (SHR) had significantly higher blood pressure than normotensive
Wistar rats (Figure 1A). Blood pressure was not affected by mTBI in either normotensive or hypertensive
rats (Figure 1A). We found that mTBI led to a significant disruption of the blood-brain barrier detected
two weeks after mTBI in hypertensive rats (n = 7), as shown by increased Evans blue content of
cerebral tissue of these animals. No leakage of Evans blue dye could be observed in normotensive
rats (n = 7), indicating intact BBB after mTBI (Figure 1B). We found that two weeks after mild TBI
fibrin accumulated in cortical tissue of hypertensive rats (n = 6), which could not be observed in SHRs
without mTBI (n = 6) or normotensive rats with and without mTBI (n = 6, in both groups) (Figure 1C).
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Figure 1. Mild traumatic brain injury (TBI) induces persistent disruption of the blood brain barrier 
and extravasation of blood borne substances in hypertensive rats. (A) shows blood pressure of Wistar 
rats and spontaneously hypertensive rats (SHR) with and without mild traumatic brain injury (mTBI) 
measured by the tail-cuff method. Data are means ± S.E.M. (n = 6 in each group) * p < 0.05 vs. Wistar, 
& p < 0.05 vs. Wistar + mTBI. (B) Summary data show blood brain barrier permeability indicated by 
extravasated Evans blue content of cerebral tissue (depicted as fold change compared to control) in 
sham operated Wistar rats and SHRs, and in rats two weeks after mTBI. Data are means ± S.E.M. (n = 
6 in each group) * p < 0.05 vs. Wistar, & p < 0.05 vs. Wistar + mTBI, $ p < 0.05 vs. SHR. (C) One 
representative Western blot presents fibrin level in perfused cerebral tissue from Wistar and 
spontaneously hypertensive rats (SHR) with and without mild traumatic brain injury (mTBI) 
(showing two in each group) two weeks after trauma. Summary data depicts cerebral fibrin protein 
level in cortical tissue of the above groups of animals. Data are means ± S.E.M. (n = 6 in each group) * 
p < 0.05 vs. Wistar, & p < 0.05 vs. Wistar + mTBI. 
Figure 1. Mild traumatic brain injury (TBI) induces persistent disruption of the blood brain barrier
and extravasation of blood borne substances in hypertensive rats. (A) shows blood pressure of Wistar
rats and spontaneously hypertensive rats (SHR) with and without mild traumatic brain injury (mTBI)
measured by the tail-cuff method. Data are means ± S.E.M. (n = 6 in each group) * p < 0.05 vs. Wistar,
& p < 0.05 vs. Wistar + mTBI. (B) Summary data show blood brain barrier permeability indicated
by extravasated Evans blue content of cerebral tissue (depicted as fold change compared to control)
in sham operated Wistar rats and SHRs, and in rats two weeks after mTBI. Data are means ± S.E.M.
(n = 6 in each group) * p < 0.05 vs. Wistar, & p < 0.05 vs. Wistar + mTBI, $ p < 0.05 vs. SHR.
(C) One representative Western blot presents fibrin level in perfused cerebral tissue from Wistar and
spontaneously hypertensive rats (SHR) with and without mild traumatic brain injury (mTBI) (showing
two in each group) two weeks after trauma. Summary data depicts cerebral fibrin protein level in
cortical tissue of the above groups of animals. Data are means ± S.E.M. (n = 6 in each group) * p < 0.05
vs. Wistar, & p < 0.05 vs. Wistar + mTBI.
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2.2. Mild TBI Induces Persistent Neuroinflammation and Cognitive Decline in Spontaneously Hypertensive Rats
We found that expression of inflammatory cytokines IL-1β, IL-6 and TNFα was significantly
(p < 0.05) increased in both cortical and hippocampal tissue of spontaneously hypertensive rats (n = 8)
two weeks after mTBI compared to sham-operated SHRs (n = 8) and to normotensive Wistar rats with
and without mTBI (n = 8 in both groups) (Figure 2A,B).
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open field test normotensive Wistar animals showed attenuated exploratory activity (number of 
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locational memory function. In contrast, SHRs did not show habituation to the environment in the 
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Figure 2. Mild TBI induces persistent neuroinflammation and cognitive decline in hypertensive rats.
(A,B) mRNA expression of inflammatory cytokines IL1β, IL6 and TNFα in cortical (A) and hippocampal
(B) tissue of sham operated normotensive Wistar rats and SHRs, and of animals two weeks after mild
TBI, expressed as fold change compared to control. Data are means ± S.E.M. (n = 8 in each group)
* p < 0.05 vs. Wistar, & p < 0.05 vs. Wistar + mTBI, $ p < 0.05 vs. SHR. (C) In a standard open field test
normotensive Wistar animals showed attenuated exploratory activity (number of crossings) two weeks
after mTBI (Wistar + mTBI) indicating habituation to the environment and intact locational memory
function. In contrast, SHRs did not show habituation to the environment in t repeated open field test
(OFT) session two weeks after mTBI (SHRmTBI), indicating impaired l cational mem ry. Data are
means ± S.E.M. (n = 15 in each group) * p < 0.05 vs. Wistar. (D) Intermediate-term declarative emory
was ested two weeks af er mTBI by the novel object recognition test. Discrimination index was not
changed in normotensive Wistar rats two weeks after mTBI, but it was significantly decr ased in SHRs,
indicating impaired declar ve memory of the animals. Data are means ± S.E.M. (n = 5 Wistar nd
n = 11 SHR) * p < 0.05 vs. Wistar, & p < 0.05 vs. Wi tar + mTBI, $ p < 0.05 vs. SHR.
We show that two weeks after trauma normotensive Wistar rats (n = 11) exhibited a significant
(p < 0.05) decrease in the number of crossings (locomotor activity and exploration) in the open field
arena, indicating habituation to the environment thus functioning learning and memory (Figure 2C).
In contrast, SHRs (n = 11) did not show any changes in the number of crossings during the repeated
session two weeks after mTBI, indicating a decline in their learning and memory functions (Figure 2C).
We studied intermediate-term declarative memory by the novel object recognition test. We found that
mTBI resulted in a significant (p < 0.05) decrease in the Discrimination Index (DI) in SHRs (n = 11)
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assessed two weeks after trauma indicating impaired memory function. Whereas DI was not changed
in normotensive Wistar rats (n = 5), indicating preserved memory function (Figure 2D).
3. Discussion
The salient finding of the present study is that mild TBI is sufficient to induce persistent disruption
of the blood-brain barrier when pre-existing arterial hypertension is present, which is associated
with the development of cognitive dysfunction (Figures 1 and 2). These findings extend previous
results that mild TBI-induced BBB disruption reaches a peak within hours and after 2 to 3 days
post-injury [6–8], and has an important translational aspect to clinical setting: hypertensive patients
should probably be assessed and treated after mild brain trauma differently than normotensive subjects.
Our results also raise the possibility, that other co-morbidities known to increase the vulnerability of
the cerebrovasculature to various insults, such as diabetes or obesity [13] would also exacerbate BBB
disruption following mTBI and lead to cognitive decline. These possibilities should be verified by
future studies.
The mechanisms by which hypertension and mild TBI interact to promote persistent disruption of
the BBB are likely multifaceted. Both TBI and hypertension have been shown to induce overproduction
of reactive oxygen species [14–16]. Although mild TBI results in a transient increase in reactive oxygen
species (ROS) generation [17], co-existing hypertension may exaggerate and extend production of ROS
in the cerebrovasculature. ROS can directly damage tight junction proteins of the BBB [18], and activate
redox sensitive matrix metalloproteinases [19], resulting in increased permeability of the barrier. Other
proteases, like caspase, known to be activated in hypertension [20,21], may contribute to the process.
These possibilities should be tested by future studies.
We found that mild TBI leads to accumulation of fibrin in cerebral tissue of hypertensive rats
(Figure 1). Previous studies suggested that the link between BBB disruption and neurological
dysfunction is the accumulation of toxic blood borne substances in the brain parenchyma. For instance,
in mice deficient of pericytes the injured BBB allows the deposition of fibrinogen in brain
parenchyma [22], which is associated with activation of the monocyte/macrophage system [23],
the increasing number of microglia and the increased production of ROS [24], further activation of
proteases and production of inflammatory cytokines. According to this pathological process, we also
found that two weeks after mild TBI production of inflammatory cytokines IL-1β, IL-6 and TNFα is
significantly enhanced in the cortices and hippocampi of hypertensive rats compared to normotensive
animals (Figure 2A,B), indicating mTBI-induced persistent neuroinflammation in SHRs. Inflammatory
cytokines further promote BBB damage [25], probably producing a positive feed back loop and
perpetuating the pathological process. There is most likely a causal link between mild TBI-induced
persistent neuroinflammation and cognitive deficit (Figure 2C,D). This is supported by studies showing
that in the mouse hippocampus chronic neuroinflammation structurally modifies axons and dendrites
of neurons and dysregulates genes involved in regulation of neuronal function (such as Bdnf, Homer1,
and Dlg4) [26,27], which may have a role in impaired synaptic plasticity and impaired cognitive
function [26].
Limitations of the Study
Despite the clear difference in cognitive function after mTBI in normotensive and hypertensive rats,
due to within-subject study design, we cannot exclude that Wistar rats would exhibit better learning
and memory function than those with mTBI. Brain trauma may induce an acute, transient increase in
blood pressure, which can be recorded by continuous measurement of blood pressure, for example
with telemetry. Lack of these data is a limitation of our studies. Hypertension has deleterious
effects in addition to the direct effect of high blood pressure. Therefore, future studies should test
whether treated hypertension exacerbates the effect of mild traumatic brain injury on BBB disruption,
neuroinflammation and cognitive decline, as well.
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4. Materials and Methods
4.1. Mild Traumatic Brain Injury (mTBI) in Normotensive and Hypertensive Rats
All procedures were approved by the Institutional Animal Use and Care Committee of the
University of Pecs Medical School and the National Scientific Ethical Committee on Animal
Experimentation, Hungary (nr: BAI/35/51-107/2016 on 25 October 2016) and carried out in accordance
with the ARRIVE guidelines. Spontaneously hypertensive rats (SHR, male, 300–350 g, n = 30) and
age-matched normotensive Wistar rats (Wistar, male, 300–350 g, n = 30) were purchased from Janvier
Labs (Le Genest-Saint-Isle, France) and Toxi-Coop (Budapest, Hungary). Mild impact acceleration
diffuse brain injury was induced by Marmarou’s weight drop model. Under isoflurane (2%) anesthesia
the skull was exposed by a midline incision between the lambda and bregma and a steel disc was
fixed with cement on the skull. A 450 g cylindrical weight from 250 mm was dropped to the disc
causing mild diffuse traumatic brain injury to the animals. We aimed to apply “very mild” head injury,
therefore we chose to follow the protocols of Singh et al., who demonstrated that weight dropped
from 250 mm was sufficient to induce detectable histological, biomarker and behavioral changes in
rats [28,29].
All animals survived the procedures. Blood pressure was measured 14 days after TBI before
further experiments in all groups of animals using the tail cuff method, as described [30].
4.2. Behavioral Studies
4.2.1. Open Field Test (OFT)
The open field test (OFT) was carried out in normotensive Wistar rats and SHRs (n = 15) before
and two weeks after mTBI. The OFT arena is a black plywood box surrounded by walls. The floor of
the arena is divided with gray lines to four by four equal squares. In each session, rats were allowed to
explore the arena for 5 min. After each rat, the box was thoroughly cleaned using 20 v/v % ethanol.
The sessions were recorded using a video camera (JVC super LoLux, JVC Kenwood Holdings Inc.,
Yokohama, Japan) and Ethovision XT10 software (Noldus, Wageningen, The Netherlands). During
the sessions, the number of line crossings were registered as a measure of locomotor activity and
exploration. The activity of rodents in an open field environment tends to decrease during repeated
sessions. This habituation to the environment is considered as a measure of learning and memory
ability of rodents [31], and learning and cognitive deficit is indicated by the lack of decrease in the
number of crossings.
4.2.2. Novel Object Recognition Test (NOR)
Declarative memory performance of the animals was assessed by the novel object recognition test
(NOR) two weeks after mTBI in normotensive Wistar rats and SHRs. The NOR test consisted of two
trials. Trial #1 (acquisition): two identical objects were placed in the arena, and the rats were allowed
to explore them for 3 min. Then, the animals were removed from the arena. Trial #2 (recognition):
after 30 min retention time, one of the objects from the 1st trial (familiar object) and a novel object were
placed in the arena, and the behavior of the rats was recorded for 3 min. The animal was considered
to be exploring an object when he was sniffing the object or put his nose close to it while facing the
object. Time spent with the exploration of the novel (En) and the familiar (Ef) objects were compared by
calculating a discrimination index (DI) using the following equation: DI = (En − Ef)/(En + Ef). The DI
was a positive number if the novel object was observed for a longer time than the familiar object,
and the DI was negative if the observation of the familiar object was longer than that of the novel
object. DI was around zero if the two objects were observed for equally long time.
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4.3. Blood-Brain Barrier Disruption
Blood-brain barrier permeability was assessed in normotensive Wistar and spontaneously
hypertensive rats (n = 7) two weeks after mild TBI by the Evans blue extravasation method. In brief,
rats were anesthetized (isoflurane (2%)) and 2% Evans blue dye was administered intraperitoneally
(7 mL/kg). The dye was allowed to circulate for 3 h. Then, the animals were transcardially perfused
with PBS, decapitated, and the brains were removed. Right hemispheres were separated, weighed and
homogenized in trichloroacetic acid (TCA) solution (50% TCA diluted in 0.9% saline). The samples
were then centrifuged (12,000 rpm for 20 min), and absorbance of supernatants was measured at
630 nm with a spectrophotometer (BioTek Synergy HT Multi-Detection Microplate Reader (BioTek
Instruments, Inc., Winooski, VT, USA).
4.4. Western Blotting
Cortical samples from normotensive Wistar rats and spontaneously hypertensive rats with and
without mild TBI (n = 6) were homogenized on ice using 400 µL of modified RIPA buffer containing
10% methanol, protease and phosphatase inhibitors (1:200, 1:100 respectively). The lysate was agitated
on 4 ◦C for 2 h, then centrifuged on maximum speed for 15 min. Lysates of samples were stored at
−30 ◦C prior to Bradford’s protein assay. Following the protein concentration assay, the supernatant
was suspended in Laemmli sample buffer (SigmaAldrich, Budapest, Hungary) and was heated to
100 ◦C for 15 min. Gel electrophoresis was carried out using mini-PROTEAN electrophoresis cell
(Bio-Rad, Hercules, CA, USA), applying 80 and 120 V in stacking and developing regions. Blotting was
carried out in a Novex Mini-Cell wet blotter (Invitrogen, Carlsbad, CA, USA) applying 450 mA for 2 h.
Non-specific binding sites were blocked with 5% milk/TBS on room temperature for 2 h then incubated
with primary antibodies overnight (Vinculin, #13901 Cell Signaling, Budapest, Hungary, and Fibrin
GTX19079 GeneTex, Irvine, CA, USA) in 3% bovine serum albumin. Rinsing was performed with 0.1%
Tween20/TBS, five times, then incubated with secondary HRP linked antibody on room temperature
for 2 h. After series of rinsing of TBS-Tween, the blot was imaged using A Fujifilm CCD imager and
densities were evaluated using ImageJ software [32].
4.5. Quantitative Real-Time RT-PCR
Total RNA was isolated from cortex and hippocampus of rats from each group (n = 8) using
NucleoSpin RNA (Macherey-Nagel GmbH, Düren, Germany) and purity and concentration were
analyzed by NanoDrop. RNA was reverse-transcribed into cDNA with the High Capacity cDNA
RT Kit (Life Technologies, Carlsbad, CA, USA). RT-PCR was run on an ABI-PRISM 7500 machine in
duplicates using SensiFast SYBR Green (BioLine, London, UK). The following primers were used: il1,
forward: 5’-GAG TCT GCA CAG TTC CCC AA-3’, reverse: 5’-ATG TCC CGA CCA TTG CTG TT-3’;
il6, forward: 5’-CAC AAG TCC GGA GAG GAG AC-3’, reverse: 5’-GCC ATT GCA CAA CTC TTT
TCT CA-3’; tnfα, forward: 5’-CAG CAA CTC CAG AAC ACC CT-3’, reverse: 5’-GGA GGG AGA TGT
GTT GCC TC-3’; βactin, forward: 5’-GTA ACC CGT TGA ACC CCA TT-3’, reverse: 5’-CCA TCC AAT
CGG TAG TAG CG-3’. Results are shown as percentage of housekeeping gene and expressed as fold
change compared to control. Quantification was performed using the ∆∆CT method.
4.6. Statistical Analysis
Data were analyzed by analysis of variance (ANOVA) and Tukey’s post hoc test. Behavioral
experiments were evaluated by two-way mixed ANOVA with within-subject factor of pre- and
post-injury measurements, and between-subject factor of groups (i.e., Wistar and SHR). A p value less
than 0.05 was considered statistically significant. Data are expressed as mean ± S.E.M.
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5. Conclusions
In conclusion, we show that in hypertensive rats, mild brain trauma is sufficient to cause a
persistent disruption of the blood-brain barrier, which is associated with accumulation of toxic
blood borne substances in the brain parenchyma, neuroinflammation and cognitive decline of the
animals. We propose that hypertensive patients with mild TBI should be assessed differently than
normotensive patients (by quantifying BBB function, cognitive function etc.), and the mechanisms
by which hypertension and mild TBI interact should be established in order to selectively target BBB
function and achieve neuroprotection in this patient population.
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